Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 304 articles:
HTML format



Single Articles


    July 2021
  1. ADABAG S, Madjid M, Cheng A
    An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
    Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
    PubMed    



  2. Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
    Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
    PubMed    


  3. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available


    June 2021

  4. Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
    Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
    PubMed    


  5. VAN DER REE MH, Postema PG
    What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
    Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
    PubMed    


  6. SCHNABEL RB, Fabritz L, Kirchhof P
    Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
    Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
    PubMed    



  7. Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
    PubMed    


  8. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
    Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
    Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
    PubMed     Abstract available


  9. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  10. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  11. PARK S, Lee S, Kim Y, Lee Y, et al
    Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
    Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
    PubMed     Abstract available


  12. BENN M
    Atrial Fibrillation And Chronic Kidney Disease.
    Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
    PubMed    


  13. TOMSITS P, Clauss S, Kaab S
    Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
    Eur Heart J. 2021;42:1972-1975.
    PubMed    


  14. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed     Abstract available


  15. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    PubMed     Abstract available


  16. STEINBERG C, Davies B, Mellor G, Tadros R, et al
    Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
    PubMed     Abstract available


  17. CSENGERI D, Sprunker NA, Schnabel RB
    Alcohol and atrial fibrillation: dose matters, not so much the type.
    Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
    PubMed    


  18. MESSERLI FH, Dobner S
    Alcohol and atrial fibrillation: not all drinks are created equal.
    Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
    PubMed    


  19. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


  20. GNECCHI M, Sala L, Schwartz PJ
    Precision Medicine and cardiac channelopathies: when dreams meet reality.
    Eur Heart J. 2021;42:1661-1675.
    PubMed     Abstract available


  21. DELISE P
    Risk stratification in Brugada syndrome: the challenge of the grey zone.
    Eur Heart J. 2021;42:1696-1697.
    PubMed    


  22. PROBST V, Goronflot T, Anys S, Tixier R, et al
    Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
    Eur Heart J. 2021;42:1687-1695.
    PubMed     Abstract available


  23. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
    Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
    Eur Heart J. 2021;42:1714.
    PubMed    


    April 2021
  24. GALIUTO L, Volpe M
    Cryoblation as first-line treatment of new-onset atrial fibrillation?
    Eur Heart J. 2021;42:1543-1544.
    PubMed    


  25. SMOLDEREN KG, Burg MM
    A broken heart after child loss.
    Eur Heart J. 2021;42:1496-1498.
    PubMed    


  26. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021

  27. Corrigendum to: Long-term outcomes in young patients with atrioventricular block of unknown aetiology.
    Eur Heart J. 2021 Mar 31. pii: 6205935. doi: 10.1093.
    PubMed    


  28. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
    Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
    Eur Heart J. 2021;42:1270-1272.
    PubMed    


  29. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
    Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
    Eur Heart J. 2021;42:1273-1274.
    PubMed    


  30. DE JONG Y, Fu EL, van Diepen M, Trevisan M, et al
    Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
    Eur Heart J. 2021 Mar 26. pii: 6188994. doi: 10.1093.
    PubMed     Abstract available


  31. OYAMA K, Giugliano RP, Berg DD, Ruff CT, et al
    Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2021 Mar 24. pii: 6184829. doi: 10.1093.
    PubMed     Abstract available


  32. CAUTI FM, Rossi P, Sommer P
    The sympathetic nervous system and ventricular arrhythmias: an inseparable union.
    Eur Heart J. 2021 Mar 23. pii: 6181767. doi: 10.1093.
    PubMed    


  33. POSTEMA PG, Walsh R, Bezzina CR
    Illuminating the path from genetics to clinical outcome in Brugada syndrome.
    Eur Heart J. 2021;42:1091-1093.
    PubMed    


  34. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
    Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
    Eur Heart J. 2021;42:1073-1081.
    PubMed     Abstract available


  35. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
    Brugada syndrome genetics is associated with phenotype severity.
    Eur Heart J. 2021;42:1082-1090.
    PubMed     Abstract available


  36. ROSSO R, Hochstadt A, Viskin D, Chorin E, et al
    Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
    Eur Heart J. 2021 Mar 10. pii: 6166275. doi: 10.1093.
    PubMed     Abstract available


  37. MARTINS RP, Baruteau AE, Daubert JC
    Poor prognosis in young patients with atrioventricular block of unknown aetiology: who is to blame? The physician or the pacemaker?
    Eur Heart J. 2021 Mar 8. pii: 6162692. doi: 10.1093.
    PubMed    


  38. IRIART X, Metras A, Coiffic A, Thambo JB, et al
    Late device-related thrombus after left atrial appendage closure: never let your guard down.
    Eur Heart J. 2021;42:1050.
    PubMed    


    February 2021
  39. ENGLER D, Heidbuchel H, Schnabel RB
    Digital, risk-based screening for atrial fibrillation in the European community-the AFFECT-EU project funded by the European Union.
    Eur Heart J. 2021 Feb 20. pii: 6145319. doi: 10.1093.
    PubMed    


  40. DIDERIKSEN JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Long-term outcomes in young patients with atrioventricular block of unknown aetiology.
    Eur Heart J. 2021 Feb 18. pii: 6143533. doi: 10.1093.
    PubMed     Abstract available


  41. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    PubMed    



  42. Corrigendum to: Predicted Benefit of an Implantable Cardioverter-Defibrillator: The MADIT-ICD Benefit Score.
    Eur Heart J. 2021 Feb 7. pii: 6130061. doi: 10.1093.
    PubMed    


  43. CREA F
    Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic.
    Eur Heart J. 2021;42:361-364.
    PubMed    


  44. BORIANI G, Vitolo M
    COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease.
    Eur Heart J. 2021;42:529-532.
    PubMed    


  45. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
    The year in cardiovascular medicine 2020: arrhythmias.
    Eur Heart J. 2021;42:499-507.
    PubMed     Abstract available


  46. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
    Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
    Eur Heart J. 2021;42:544.
    PubMed    


    January 2021
  47. WEI D, Olofsson T, Chen H, Janszky I, et al
    Death of a child and the risk of atrial fibrillation: a nationwide cohort study in Sweden.
    Eur Heart J. 2021 Jan 30. pii: 6124028. doi: 10.1093/eurheartj/ehaa1084.
    PubMed     Abstract available


  48. SULZGRUBER P, Doehner W, Niessner A
    Valvular atrial fibrillation and a CHA2DS2-VASc score of 1-a statement of the ESC working group on cardiovascular pharmacotherapy and ESC council on stroke.
    Eur Heart J. 2021 Jan 26. pii: 6120259. doi: 10.1093/eurheartj/ehaa1081.
    PubMed    


  49. AL-KHAYATT BM, Salciccioli JD, Marshall DC, Krahn AD, et al
    Paradoxical impact of socioeconomic factors on outcome of atrial fibrillation in Europe: trends in incidence and mortality from atrial fibrillation.
    Eur Heart J. 2021 Jan 25. pii: 6120042. doi: 10.1093/eurheartj/ehaa1077.
    PubMed     Abstract available


  50. RIENSTRA M, Van Gelder IC
    Incidence and outcome of atrial fibrillation: diversity throughout Europe.
    Eur Heart J. 2021 Jan 25. pii: 6120041. doi: 10.1093/eurheartj/ehaa1078.
    PubMed    


  51. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    PubMed    


  52. CSENGERI D, Sprunker NA, Di Castelnuovo A, Niiranen T, et al
    Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes.
    Eur Heart J. 2021 Jan 13. pii: 6090248. doi: 10.1093.
    PubMed     Abstract available


  53. WONG JA, Conen D
    Alcohol consumption, atrial fibrillation, and cardiovascular disease: finding the right balance.
    Eur Heart J. 2021 Jan 13. pii: 6090247. doi: 10.1093.
    PubMed    


  54. YOUNIS A, Goldberger JJ, Kutyifa V, Zareba W, et al
    Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
    Eur Heart J. 2021 Jan 8. pii: 6071721. doi: 10.1093/eurheartj/ehaa1057.
    PubMed     Abstract available


  55. GALIUTO L, Patrono C
    Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve.
    Eur Heart J. 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
    PubMed    


  56. ORAII A, Bozorgi A, Tajdini M
    Differences in the 2020 ESC versus 2019 ACC/AHA/HRS guidelines on atrial fibrillation.
    Eur Heart J. 2021 Jan 4. pii: 6062049. doi: 10.1093/eurheartj/ehaa1098.
    PubMed    


  57. HAMILTON GW, Lim HS
    Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
    Eur Heart J. 2021;42:133.
    PubMed    


    December 2020
  58. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed     Abstract available


  59. BARRA S, Narayanan K, Garcia R, Marijon E, et al
    Time to revisit implantable cardioverter-defibrillator implantation criteria in women.
    Eur Heart J. 2020 Dec 23. pii: 6046140. doi: 10.1093.
    PubMed    


  60. TAMURA S, Shimeno K, Abe Y, Naruko T, et al
    A right-to-left atrial shunt via an iatrogenic atrial septal defect after atrial fibrillation ablation induced by a percutaneous left ventricular assist device.
    Eur Heart J. 2020 Dec 16. pii: 6035373. doi: 10.1093/eurheartj/ehaa1027.
    PubMed    


  61. O'SHEA CJ, Thomas G, Middeldorp ME, Harper C, et al
    Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.
    Eur Heart J. 2020 Dec 16. pii: 6035202. doi: 10.1093.
    PubMed     Abstract available


  62. WILDE AAM, Lodder EM
    Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
    Eur Heart J. 2020;41:4523-4524.
    PubMed    


  63. HAMILTON RM, Chatterjee D, Saguner AM
    Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
    Eur Heart J. 2020;41:4521-4522.
    PubMed    


  64. PASCALE P, Haddad C
    Uninterrupted vs. interrupted non-vitamin K antagonist oral anticoagulant during atrial fibrillation catheter ablation: expert opinion or true evidence?
    Eur Heart J. 2020 Dec 9. pii: 6028512. doi: 10.1093/eurheartj/ehaa1000.
    PubMed    


  65. MARTINI B
    Six young patients resuscitated from ventricular fibrillation between 1980 and 1989.
    Eur Heart J. 2020;41:4384-4387.
    PubMed    


    November 2020

  66. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Nov 26. pii: 6006712. doi: 10.1093.
    PubMed    


  67. FAZZARI F
    A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2020 Nov 25. pii: 6006471. doi: 10.1093.
    PubMed    


  68. SIMONS SO, Elliott A, Sastry M, Hendriks JM, et al
    Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective.
    Eur Heart J. 2020 Nov 18. pii: 5989803. doi: 10.1093.
    PubMed     Abstract available


  69. ARSENOS P, Antoniou CK, Gatzoulis KA
    Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
    Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.
    PubMed    


  70. VERHAMME P, Budts W, Van de Werf F
    Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
    Eur Heart J. 2020;41:4178-4180.
    PubMed    


  71. COLLET JP, Thiele H
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 13. pii: 5981490. doi: 10.1093.
    PubMed    


  72. CAMM AJ
    Does ablation of atrial fibrillation reduce the likelihood of dementia? A step closer but not yet there.
    Eur Heart J. 2020 Nov 11. pii: 5974605. doi: 10.1093.
    PubMed    


  73. MILLENAAR D, Bohm M
    Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure.
    Eur Heart J. 2020 Nov 9. pii: 5964151. doi: 10.1093.
    PubMed    


  74. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
    PubMed    


  75. BARRIOS V, Escobar C
    Atrial fibrillation, an equivalent of cardiovascular disease risk.
    Eur Heart J. 2020 Nov 9. pii: 5964152. doi: 10.1093.
    PubMed    


  76. MEIER S, Yu C, Raju H, Naoum C, et al
    Incidental diagnosis of arrhythmogenic right ventricular cardiomyopathy on coronary computed tomography angiography in a septuagenarian.
    Eur Heart J. 2020 Nov 9. pii: 5964155. doi: 10.1093.
    PubMed    


  77. IRIGARAY SIERRA P, Gayan Ordas J, Pastor Pueyo P, Viles Bertran D, et al
    Abdominal pain and atrioventricular block: beyond pacemaker implantation.
    Eur Heart J. 2020 Nov 9. pii: 5964171. doi: 10.1093.
    PubMed    


  78. NANJO A, Evans H, Direk K, Hayward AC, et al
    Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records.
    Eur Heart J. 2020;41:4011-4020.
    PubMed     Abstract available


    October 2020
  79. SAMA IE, Voors AA, van Veldhuisen DJ
    New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease.
    Eur Heart J. 2020 Oct 29. pii: 5942721. doi: 10.1093.
    PubMed    


  80. FANAROFF AC, Lopes RD
    Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy.
    Eur Heart J. 2020 Oct 25. pii: 5939783. doi: 10.1093.
    PubMed    


  81. GALIUTO L, Patrono C
    Early rhythm control for early atrial fibrillation? Comment on the EAST-AFNET 4 Trial.
    Eur Heart J. 2020 Oct 25. pii: 5939827. doi: 10.1093.
    PubMed    


  82. BOERSMA LVA
    Surgical or catheter ablation for longstanding persistent atrial fibrillation: a game of rock paper scissors?
    Eur Heart J. 2020 Oct 17. pii: 5929304. doi: 10.1093.
    PubMed    


  83. LIUZZO G, Patrono C
    Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
    Eur Heart J. 2020 Oct 17. pii: 5927543. doi: 10.1093.
    PubMed    


  84. SCHWARTZ PJ
    1970-2020: 50 years of research on the long QT syndrome-from almost zero knowledge to precision medicine.
    Eur Heart J. 2020 Oct 15. pii: 5923771. doi: 10.1093.
    PubMed     Abstract available



  85. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Oct 8. pii: 5919233. doi: 10.1093.
    PubMed    


  86. KIM D, Yang PS, Sung JH, Jang E, et al
    Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2020 Oct 6. pii: 5918337. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  87. DISERTORI M, Mase M, Nollo G
    Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio.
    Eur Heart J. 2020 Sep 30. pii: 5913137. doi: 10.1093.
    PubMed    


  88. WALLENTIN L, Lindback J, Eriksson N, Hijazi Z, et al
    Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Eur Heart J. 2020 Sep 27. pii: 5912214. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  89. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  90. HALDAR S, Khan HR, Boyalla V, Kralj-Hans I, et al
    Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial.
    Eur Heart J. 2020 Aug 29. pii: 5898905. doi: 10.1093.
    PubMed     Abstract available


  91. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  92. MARONA M, Celinska-Spodar M, Spiewak M, Konopka A, et al
    Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.
    Eur Heart J. 2020;41:2921.
    PubMed    


  93. LUSCHER TF
    Optimizing management of atrial fibrillation: integrated care, blood pressure control, ablation, and left atrial appendix occlusion.
    Eur Heart J. 2020;41:2821-2825.
    PubMed    


  94. WILDE AAM, Lodder EM
    A highly specific biomarker for Brugada syndrome. Also too good to be true?
    Eur Heart J. 2020;41:2891-2893.
    PubMed    


  95. HOLMES DR, Alkhouli M
    Rebellious palpitations.
    Eur Heart J. 2020;41:2902-2903.
    PubMed    


  96. BLASZYK K, Gwizdala A
    Narrow or broad QRS tachycardia: does 120 ms matter?
    Eur Heart J. 2020;41:2908.
    PubMed    


  97. FUKUMA T, Fujimoto N, Ishiyama M, Dohi K, et al
    Atrial wall thickening, fevers, and atrial fibrillation caused by immunoglobulin G4-related biatrial cardiomyopathy.
    Eur Heart J. 2020 Aug 3. pii: 5879863. doi: 10.1093.
    PubMed    


    July 2020
  98. INCIARDI RM, Adamo M, Lupi L, Metra M, et al
    Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?
    Eur Heart J. 2020 Jul 22. pii: 5875228. doi: 10.1093.
    PubMed    


  99. SANCHIS-GOMAR F, Perez-Quilis C, Lavie CJ
    Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
    Eur Heart J. 2020 Jul 20. pii: 5874071. doi: 10.1093.
    PubMed    


  100. BLOMSTROM-LUNDQVIST C
    Effects of COVID-19 lockdown strategies on management of atrial fibrillation.
    Eur Heart J. 2020 Jul 2. pii: 5866605. doi: 10.1093.
    PubMed    


    June 2020
  101. HOLT A, Gislason GH, Schou M, Zareini B, et al
    New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.
    Eur Heart J. 2020 Jun 24. pii: 5861973. doi: 10.1093.
    PubMed     Abstract available


  102. DUSI V, De Ferrari GM, Schwartz PJ
    There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias.
    Eur Heart J. 2020;41:2180-2182.
    PubMed    


  103. AZARKISH M, Laleh Far V, Eslami M, Mollazadeh R, et al
    Transient complete heart block in a patient with critical COVID-19.
    Eur Heart J. 2020;41:2131.
    PubMed    


  104. LINZ D, Pluymaekers NAHA, Hendriks JM
    TeleCheck-AF for COVID-19.
    Eur Heart J. 2020;41:1954-1955.
    PubMed    


    May 2020
  105. SHANTSILA A, Shantsila E, Lip GYH
    Blood pressure targets in atrial fibrillation.
    Eur Heart J. 2020 May 27. pii: 5847949. doi: 10.1093.
    PubMed    


  106. MARK ESTES NA, Saba S
    Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap.
    Eur Heart J. 2020 May 19. pii: 5840425. doi: 10.1093.
    PubMed    


  107. INCIARDI RM, Adamo M, Lupi L, Cani DS, et al
    Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
    Eur Heart J. 2020;41:1821-1829.
    PubMed     Abstract available


  108. SUGIYAMA T
    Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants.
    Eur Heart J. 2020 May 7. pii: 5831946. doi: 10.1093.
    PubMed    


  109. HUANG HK, Yeh JI, Loh CH
    Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants: a meta-analysis based on current observational studies.
    Eur Heart J. 2020 May 7. pii: 5831944. doi: 10.1093.
    PubMed    


  110. ZABEL M, Willems R, Lubinski A, Bauer A, et al
    Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
    Eur Heart J. 2020 May 6. pii: 5830833. doi: 10.1093.
    PubMed     Abstract available


  111. GUO Y, Lane DA, Chen Y, Lip GYH, et al
    Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation.
    Eur Heart J. 2020;41:1617-1619.
    PubMed    


  112. GARGIULO G, Goette A, Vranckx P, Valgimigli M, et al
    Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help.
    Eur Heart J. 2020;41:1701-1702.
    PubMed    


    April 2020
  113. DURU F, Brunckhorst C
    Recipient of the 2019 Zurich Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Research Prize in Basic Science.
    Eur Heart J. 2020;41:1538.
    PubMed    


  114. MAURY P, Rollin A, Voglimacci-Stephanopoli Q, Delmas C, et al
    Termination of sustained ventricular fibrillation by catheter ablation.
    Eur Heart J. 2020 Apr 15. pii: 5820564. doi: 10.1093.
    PubMed    


  115. SACHECK JM, Mozaffarian D
    Physical activity in patients with existing atrial fibrillation: time for exercise prescription?
    Eur Heart J. 2020;41:1476-1478.
    PubMed    


  116. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.
    PubMed    


  117. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  118. KUWABARA M, Borghi C, Johnson RJ
    Febuxostat and atrial fibrillation.
    Eur Heart J. 2020 Mar 30. pii: 5813683. doi: 10.1093.
    PubMed    


  119. GOLDENBERG I, Huang DT, Nielsen JC
    The role of implantable cardioverter-defibrillators in asymptomatic patients with left ventricular dysfunction.
    Eur Heart J. 2020 Mar 25. pii: 5811613. doi: 10.1093.
    PubMed    


  120. VAN DER LINGEN ACJ, Allaart CP
    The role of implantable cardioverter-defibrillators in New York Heart Class I heart failure patients: do not abandon the asymptomatic just yet.
    Eur Heart J. 2020 Mar 25. pii: 5811615. doi: 10.1093.
    PubMed    


  121. LUSCHER TF
    Challenges in atrial fibrillation: detection, alert systems, fibrosis, and infection.
    Eur Heart J. 2020;41:1063-1066.
    PubMed    


  122. DE CATERINA R, Mundi S, Fusaro M
    Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs.
    Eur Heart J. 2020;41:1109-1111.
    PubMed    


  123. STEINBERG BA, Piccini JP
    Call me maybe? The right time and place for BPAs in EHRs.
    Eur Heart J. 2020;41:1097-1099.
    PubMed    


    February 2020
  124. VAN DEN DRIES CJ, van Doorn S, Rutten FH, Oudega R, et al
    Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial.
    Eur Heart J. 2020 Feb 29. pii: 5762631. doi: 10.1093.
    PubMed     Abstract available


  125. AGASTHI P, Tseng A, Mulpuru SK
    Appropriate cohort selection and its impact on a meta-analysis evaluating the efficacy of direct oral anticoagulants post-percutaneous coronary intervention.
    Eur Heart J. 2020 Feb 14. pii: 5736264. doi: 10.1093.
    PubMed    


  126. GARNVIK LE, Malmo V, Janszky I, Ellekjaer H, et al
    Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study.
    Eur Heart J. 2020 Feb 11. pii: 5733768. doi: 10.1093.
    PubMed     Abstract available


  127. CORRADO D, Cipriani A, De Lazzari M, Perazzolo Marra M, et al
    Right ventricular dilatation in arrhythmogenic right ventricular cardiomyopathy: need for a revision of the 2010 International Task Force criteria.
    Eur Heart J. 2020 Feb 7. pii: 5729976. doi: 10.1093.
    PubMed    


  128. KHANJI MY, Chahal AA, Lopes LR, Petersen SE, et al
    Cardiovascular magnetic resonance imaging volume criteria for arrhythmogenic right ventricular cardiomyopathy: need for update?
    Eur Heart J. 2020 Feb 7. pii: 5729983. doi: 10.1093.
    PubMed    


  129. RASMUSSEN PV, Dalgaard F, Gislason GH, Brandes A, et al
    Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation.
    Eur Heart J. 2020 Feb 7. pii: 5728596. doi: 10.1093.
    PubMed     Abstract available


  130. HUANG HK, Liu PP, Hsu JY, Lin SM, et al
    Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study.
    Eur Heart J. 2020 Feb 1. pii: 5718429. doi: 10.1093.
    PubMed     Abstract available


  131. SCHMIDT AS, Lauridsen KG, Lofgren B
    Maximizing cardioversion efficacy: maximum-fixed energy shocks and what else?
    Eur Heart J. 2020;41:722.
    PubMed    


  132. EZEKOWITZ JA
    All for one, but not one for all.
    Eur Heart J. 2020;41:642-644.
    PubMed    


    January 2020
  133. SELIGMAN WH, Das-Gupta Z, Jobi-Odeneye AO, Arbelo E, et al
    Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group.
    Eur Heart J. 2020 Jan 29. pii: 5717382. doi: 10.1093.
    PubMed     Abstract available


  134. BOOS CJ
    Infection and atrial fibrillation: inflammation begets AF.
    Eur Heart J. 2020 Jan 23. pii: 5714930. doi: 10.1093.
    PubMed    


  135. NATTEL S
    Physical activity and atrial fibrillation risk: it's complicated; and sex is critical.
    Eur Heart J. 2020 Jan 17. pii: 5709153. doi: 10.1093.
    PubMed    


  136. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  137. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    PubMed    


  138. GUNDLUND A, Olesen JB, Butt JH, Christensen MA, et al
    One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study.
    Eur Heart J. 2019 Dec 17. pii: 5680017. doi: 10.1093.
    PubMed     Abstract available


  139. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    PubMed     Abstract available


  140. JONES NR, Taylor CJ, Hobbs FDR, Bowman L, et al
    Screening for atrial fibrillation: a call for evidence.
    Eur Heart J. 2019 Dec 7. pii: 5663566. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  141. LOPES RD, Hong H, Alexander JH
    Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
    Eur Heart J. 2019 Nov 27. pii: 5644218. doi: 10.1093.
    PubMed    


  142. WILLEMS S, Meyer C, de Bono J, Brandes A, et al
    Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.
    Eur Heart J. 2019 Nov 22. pii: 5637788. doi: 10.1093.
    PubMed     Abstract available


  143. GOLDENBERG I, Huang DT, Nielsen JC
    The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome.
    Eur Heart J. 2019 Nov 12. pii: 5622905. doi: 10.1093.
    PubMed     Abstract available


  144. SOHNS C, Marrouche NF
    Atrial fibrillation and cardiac fibrosis.
    Eur Heart J. 2019 Nov 12. pii: 5622908. doi: 10.1093.
    PubMed     Abstract available


  145. RAMIREZ FD, Sadek MM, Birnie DH
    Bang for the buck: the importance of modifiable factors for electrical cardioversion of atrial fibrillation.
    Eur Heart J. 2019 Nov 7. pii: 5614373. doi: 10.1093.
    PubMed    


    October 2019
  146. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


  147. HONARBAKHSH S, Prabhu S, Hunter RJ
    With our powers combined: Does the pooled analysis of existing randomized data regarding treatment of atrial fibrillation in heart failure settle the case for catheter ablation?
    Eur Heart J. 2019 Oct 22. pii: 5602553. doi: 10.1093.
    PubMed    


  148. CORRADO D, van Tintelen PJ, McKenna WJ, Hauer RNW, et al
    Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis.
    Eur Heart J. 2019 Oct 21. pii: 5602183. doi: 10.1093.
    PubMed    


  149. JAMES CA, Calkins H
    Arrhythmogenic right ventricular cardiomyopathy: evidence for progression increases.
    Eur Heart J. 2019 Oct 16. pii: 5588521. doi: 10.1093.
    PubMed    


  150. RICHTER S, Di Biase L, Hindricks G
    Atrial fibrillation ablation in heart failure: it's not all about Starling my darling.
    Eur Heart J. 2019 Oct 3. pii: 5580540. doi: 10.1093.
    PubMed    


    September 2019
  151. CHATHA SR, Westwood M, Moon JC, Captur G, et al
    New-onset heart failure: free-breathing motion-corrected late gadolinium enhancement rescues the endomyocardial fibrosis diagnosis.
    Eur Heart J. 2019 Sep 27. pii: 5575240. doi: 10.1093.
    PubMed    


  152. WIJTVLIET EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, et al
    Nurse-led vs. usual-care for atrial fibrillation.
    Eur Heart J. 2019 Sep 23. pii: 5572602. doi: 10.1093.
    PubMed     Abstract available


  153. LUSCHER TF
    Risks and management of cardioversion and catheter ablation in atrial fibrillation.
    Eur Heart J. 2019;40:2999-3002.
    PubMed    


  154. GUHA A, Dey AK, Jneid H, Ibarz JP, et al
    Atrial Fibrillation in the Era of Emerging Cancer Therapies.
    Eur Heart J. 2019;40:3007-3010.
    PubMed    


  155. LIP GYH, Guo Y, Lotufo P, Surenthirakumaran R, et al
    The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management.
    Eur Heart J. 2019;40:3005-3007.
    PubMed    


  156. SULZGRUBER P, Wassmann S, Semb AG, Doehner W, et al
    Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
    Eur Heart J. 2019;40:3010-3012.
    PubMed    


  157. VON OERTZEN TJ, Trinka E, Bornstein NM
    Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination.
    Eur Heart J. 2019 Sep 20. pii: 5572225. doi: 10.1093.
    PubMed    


  158. POTPARA T, Steffel J
    Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug-drug interaction.
    Eur Heart J. 2019 Sep 20. pii: 5572224. doi: 10.1093.
    PubMed    


    August 2019
  159. KLEIN HU
    Elective DC cardioversion of atrial fibrillation: did we use the right procedure?
    Eur Heart J. 2019 Aug 31. pii: 5554427. doi: 10.1093.
    PubMed    


  160. SCHMIDT AS, Lauridsen KG, Torp P, Bach LF, et al
    Maximum-fixed energy shocks for cardioverting atrial fibrillation.
    Eur Heart J. 2019 Aug 31. pii: 5552545. doi: 10.1093.
    PubMed     Abstract available



  161. Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
    Eur Heart J. 2019 Aug 29. pii: 5556355. doi: 10.1093.
    PubMed    


  162. BJURSTEN H, Rasmussen M, Nozohoor S, Gotberg M, et al
    Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.
    Eur Heart J. 2019 Aug 21. pii: 5552575. doi: 10.1093.
    PubMed     Abstract available


  163. VERHEUGT FWA
    Cardioversion as bystander in atrial fibrillation-related thrombo-embolism.
    Eur Heart J. 2019 Aug 7. pii: 5544748. doi: 10.1093.
    PubMed    


  164. PACKER M
    What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
    Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
    PubMed     Abstract available


  165. MCINTYRE WF, Connolly SJ, Wang J, Masiero S, et al
    Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials.
    Eur Heart J. 2019 Aug 4. pii: 5543556. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  166. FREY SM, Sticherling C, Mueller C
    Comment to: Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.
    Eur Heart J. 2019 Jul 30. pii: 5541022. doi: 10.1093.
    PubMed    


  167. GUTMAN SJ, Taylor AJ
    Reply to letter by Frey et al. regarding the article: Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.
    Eur Heart J. 2019 Jul 30. pii: 5541020. doi: 10.1093.
    PubMed    


  168. KUHNE M, Krisai P, Conen D, Osswald S, et al
    The heart-brain connection: further establishing the relationship between atrial fibrillation and dementia?
    Eur Heart J. 2019;40:2324-2326.
    PubMed    


  169. NAZIF TM, Chen S, George I, Dizon JM, et al
    New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
    Eur Heart J. 2019;40:2218-2227.
    PubMed     Abstract available


  170. KILLU AM, Gersh BJ
    Response to: Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.
    Eur Heart J. 2019 Jul 13. pii: 5532107. doi: 10.1093.
    PubMed    


  171. LI HF, Liang B, Li HY
    Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.
    Eur Heart J. 2019 Jul 13. pii: 5532108. doi: 10.1093.
    PubMed    


  172. CHEN S, Purerfellner H, Meyer C, Acou WJ, et al
    Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data.
    Eur Heart J. 2019 Jul 11. pii: 5531275. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  173. CLELAND JGF, Hindricks G, Petrie M
    The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization.
    Eur Heart J. 2019 Jun 30. pii: 5525356. doi: 10.1093.
    PubMed    


  174. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


  175. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  176. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    PubMed     Abstract available


  177. KIM D, Yang PS, Yu HT, Kim TH, et al
    Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.
    Eur Heart J. 2019 Jun 18. pii: 5520105. doi: 10.1093.
    PubMed     Abstract available


  178. DEMEESTERE J, Lemmens R
    Anticoagulation in low-risk patients with atrial fibrillation: beyond prevention of ischaemic stroke.
    Eur Heart J. 2019 Jun 18. pii: 5519990. doi: 10.1093.
    PubMed    


  179. FENG T, Vegard M, Strand LB, Laugsand LE, et al
    Weight and weight change and risk of atrial fibrillation: the HUNT study.
    Eur Heart J. 2019 Jun 17. pii: 5519674. doi: 10.1093.
    PubMed     Abstract available


  180. SCHWARTZ PJ, Woosley RL, Crotti L
    When prescribing drugs, do medical doctors and healthcare professionals realize that their patient has the long QT syndrome?
    Eur Heart J. 2019 Jun 14. pii: 5519086. doi: 10.1093.
    PubMed    


  181. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
    Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
    Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
    PubMed     Abstract available


  182. THALMANN G, Schneiter S, Kawel-Boehm N, Mayer KA, et al
    An unusual intracardiac thrombus in an 81-year-old man with severe symptomatic aortic stenosis.
    Eur Heart J. 2019 Jun 4. pii: 5510781. doi: 10.1093.
    PubMed    


  183. SHAH DC
    Longitudinal, long-term evaluation of new-onset atrial fibrillation: the interplay of blood pressure burden over time and gender.
    Eur Heart J. 2019 Jun 3. pii: 5510138. doi: 10.1093.
    PubMed    


    May 2019
  184. VAN DER WERF C, Lieve KV, Bos JM, Lane CM, et al
    Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
    Eur Heart J. 2019 May 30. pii: 5506735. doi: 10.1093.
    PubMed     Abstract available


  185. FRIBERG L, Andersson T, Rosenqvist M
    Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
    Eur Heart J. 2019 May 16. pii: 5490291. doi: 10.1093.
    PubMed     Abstract available


  186. PACKER M
    Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation.
    Eur Heart J. 2019 May 12. pii: 5488510. doi: 10.1093.
    PubMed     Abstract available


  187. WEEKE PE, Kellemann JS, Jespersen CB, Theilade J, et al
    Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality.
    Eur Heart J. 2019 May 11. pii: 5488147. doi: 10.1093.
    PubMed     Abstract available


  188. URENA M, Rodes-Cabau J
    New-onset conduction disturbances: the last obstacle in the way of transcatheter aortic valve implantation.
    Eur Heart J. 2019 May 9. pii: 5487604. doi: 10.1093.
    PubMed    


  189. SHARASHOVA E, Wilsgaard T, Ball J, Morseth B, et al
    Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromso Study.
    Eur Heart J. 2019 May 3. pii: 5485289. doi: 10.1093.
    PubMed     Abstract available


  190. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  191. VON HAEHLING S, Doehner W, Anker SD
    The evolving obesity paradigm story: from heart failure to atrial fibrillation.
    Eur Heart J. 2019 Apr 21. pii: 5476266. doi: 10.1093.
    PubMed    


  192. MCKENNA WJ, Asaad NA, Jacoby DL
    Prediction of ventricular arrhythmia and sudden death in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2019 Apr 11. pii: 5448878. doi: 10.1093.
    PubMed    


  193. HOHNLOSER SH, Camm J, Cappato R, Diener HC, et al
    Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
    Eur Heart J. 2019 Apr 11. pii: 5446017. doi: 10.1093.
    PubMed     Abstract available


  194. SCHULZ SM, Ritter O, Zniva R, Nordbeck P, et al
    Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial.
    Eur Heart J. 2019 Apr 8. pii: 5431178. doi: 10.1093.
    PubMed     Abstract available


  195. MEHRAN R, Kalkman DN, Angiolillo DJ
    Atrial fibrillation, with ACS and PCI: walking a tightrope.
    Eur Heart J. 2019 Apr 8. pii: 5431179. doi: 10.1093.
    PubMed    


  196. BONDE AN, Blanche P, Staerk L, Gerds TA, et al
    Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
    Eur Heart J. 2019 Apr 1. pii: 5424120. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  197. CHEUNG JW, Cheng EP, Wu X, Yeo I, et al
    Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.
    Eur Heart J. 2019 Mar 29. pii: 5422981. doi: 10.1093.
    PubMed     Abstract available


  198. SINGH JA, Cleveland JD
    Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.
    Eur Heart J. 2019 Mar 28. pii: 5421316. doi: 10.1093.
    PubMed     Abstract available


  199. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2019 Mar 27. pii: 5419784. doi: 10.1093.
    PubMed     Abstract available


  200. NOSEWORTHY PA, Gersh BJ, Kent DM, Piccini JP, et al
    Atrial fibrillation ablation in practice: assessing CABANA generalizability.
    Eur Heart J. 2019 Mar 15. pii: 5381200. doi: 10.1093.
    PubMed     Abstract available


  201. CAMM AJ
    Left atrial ablation for management of atrial fibrillation: CABANA vs. real-world data. Apples and oranges?
    Eur Heart J. 2019 Mar 15. pii: 5381199. doi: 10.1093.
    PubMed    


  202. CONEN D
    Alcohol and Atrial Fibrillation.
    Eur Heart J. 2019;40:796-797.
    PubMed    


    February 2019
  203. OZKARTAL T, Auricchio A, Conte G
    Ajmaline infusion during automated screening in Brugada syndrome and spontaneous Type 1 electrocardiogram unmasks non-suitability for subcutaneous implantable cardioverter-defibrillator.
    Eur Heart J. 2019 Feb 21. pii: 5359472. doi: 10.1093.
    PubMed    


  204. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
    PubMed     Abstract available


  205. VAN DEN BERG MP, Mulder BA, Klaassen SHC, Maass AH, et al
    Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.
    Eur Heart J. 2019 Feb 8. pii: 5310346. doi: 10.1093.
    PubMed     Abstract available


  206. SCHWARTZ PJ, Gnecchi M, Dagradi F, Castelletti S, et al
    From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2.
    Eur Heart J. 2019 Feb 6. pii: 5307938. doi: 10.1093.
    PubMed     Abstract available


  207. TRENKWALDER T, Schunkert H
    Risk of atrial fibrillation in big people under the magnifying glass of G. J. Mendel.
    Eur Heart J. 2019 Feb 5. pii: 5306113. doi: 10.1093.
    PubMed    


  208. TIKKANEN E, Gustafsson S, Knowles JW, Perez M, et al
    Body composition and atrial fibrillation: a Mendelian randomization study.
    Eur Heart J. 2019 Feb 5. pii: 5306116. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  209. BUNCH JT, Woller SC
    Saving the brain from catheter ablation of atrial fibrillation: the role of pre- and peri-procedural anticoagulation.
    Eur Heart J. 2019 Jan 31. pii: 5305045. doi: 10.1093.
    PubMed    


  210. VERKERK AO, Remme CA
    Down the rabbit hole: deciphering the short QT syndrome.
    Eur Heart J. 2019 Jan 27. pii: 5303207. doi: 10.1093.
    PubMed    


  211. GOLDHABER SZ, Piazza G
    Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities.
    Eur Heart J. 2019 Jan 25. pii: 5301477. doi: 10.1093.
    PubMed    


  212. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    PubMed    


  213. BORIANI G, Ruff CT, Kuder JF, Shi M, et al
    Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2019 Jan 8. pii: 5280832. doi: 10.1093.
    PubMed     Abstract available


  214. CHUA W, Purmah Y, Cardoso VR, Gkoutos GV, et al
    Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation.
    Eur Heart J. 2019 Jan 7. pii: 5270657. doi: 10.1093.
    PubMed     Abstract available


  215. KIM TH, Yang PS, Yu HT, Jang E, et al
    Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population.
    Eur Heart J. 2019 Jan 4. pii: 5273478. doi: 10.1093.
    PubMed     Abstract available


  216. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Eur Heart J. 2019 Jan 2. pii: 5272355. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  217. YU HT, Shim J, Park J, Kim TH, et al
    When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.
    Eur Heart J. 2018 Dec 27. pii: 5263768. doi: 10.1093.
    PubMed     Abstract available


  218. WANG KL, Lopes RD, Patel MR, Buller HR, et al
    Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2018 Dec 22. pii: 5255630. doi: 10.1093.
    PubMed     Abstract available


  219. CHAO TF, Chen SA, Ruff CT, Hamershock RA, et al
    Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2018 Dec 22. pii: 5258031. doi: 10.1093.
    PubMed     Abstract available


  220. RICHTER S, Di Biase L, Hindricks G
    Atrial fibrillation ablation in heart failure.
    Eur Heart J. 2018 Dec 14. pii: 5248225. doi: 10.1093.
    PubMed     Abstract available


  221. OBOKATA M, Reddy YNV, Melenovsky V, Pislaru S, et al
    Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
    Eur Heart J. 2018 Dec 12. pii: 5240922. doi: 10.1093.
    PubMed     Abstract available


  222. KILLU AM, Granger CB, Gersh BJ
    Risk stratification for stroke in atrial fibrillation: a critique.
    Eur Heart J. 2018 Dec 1. pii: 5224504. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  223. STEFFEL J, Potpara TS
    Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants.
    Eur Heart J. 2018 Nov 29. pii: 5219661. doi: 10.1093.
    PubMed    


  224. ODENING KE, Bodi I, Franke G, Rieke R, et al
    Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
    Eur Heart J. 2018 Nov 28. pii: 5212713. doi: 10.1093.
    PubMed     Abstract available


  225. LUSCHER TF
    Dangerous encounters: triggers of fatal ventricular arrhythmias and safety of interventional treatment strategies.
    Eur Heart J. 2018;39:3909-3912.
    PubMed    


  226. SIONTIS KC, Yao X, Noseworthy PA
    Atrial fibrillation in heart failure syndromes: does it matter more in some than in others?
    Eur Heart J. 2018 Nov 20. pii: 5193438. doi: 10.1093.
    PubMed    


  227. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    PubMed    


  228. NISHIMURA M, Maisel AS
    Biomarkers: a window into the pathophysiology of atrial fibrillation in heart failure with reduced vs. preserved ejection fraction.
    Eur Heart J. 2018;39:3876-3878.
    PubMed    


  229. GOLWALA H, Cannon CP, Bhatt DL
    Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 5. pii: 5161202. doi: 10.1093.
    PubMed    


  230. GRAGNANO F, Calabro P, Valgimigli M
    Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?
    Eur Heart J. 2018 Nov 5. pii: 5161206. doi: 10.1093.
    PubMed    


    October 2018
  231. BOERSMA LVA
    Biventricular pacing after AV-node ablation for atrial fibrillation with heart failure: something old and something new, future standard, or just for the few?
    Eur Heart J. 2018 Oct 25. pii: 5145027. doi: 10.1093.
    PubMed    


  232. JOHN RM, Michaud GF, Stevenson WG
    Atrial fibrillation hospitalization, mortality, and therapy.
    Eur Heart J. 2018 Oct 16. pii: 5133619. doi: 10.1093.
    PubMed    


  233. ZAFRIR B, Lund LH, Laroche C, Ruschitzka F, et al
    Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Eur Heart J. 2018 Oct 15. pii: 5133012. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  234. CALKINS H
    A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy: is this too good to be true?
    Eur Heart J. 2018 Sep 17. pii: 5098639. doi: 10.1093.
    PubMed    


  235. CHATTERJEE D, Fatah M, Akdis D, Spears DA, et al
    An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
    Eur Heart J. 2018 Sep 17. pii: 5098642. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  236. BRIGNOLE M, Pokushalov E, Pentimalli F, Palmisano P, et al
    A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
    Eur Heart J. 2018 Aug 26. pii: 5078460. doi: 10.1093.
    PubMed     Abstract available


  237. SANTEMA BT, Kloosterman M, Van Gelder IC, Mordi I, et al
    Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction.
    Eur Heart J. 2018 Aug 22. pii: 5077588. doi: 10.1093.
    PubMed     Abstract available


  238. GUTMAN SJ, Costello BT, Papapostolou S, Voskoboinik A, et al
    Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.
    Eur Heart J. 2018 Aug 10. pii: 5070406. doi: 10.1093.
    PubMed     Abstract available


  239. FREEDMAN B
    Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?
    Eur Heart J. 2018 Aug 10. pii: 5070412. doi: 10.1093.
    PubMed    


  240. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
    Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
    PubMed     Abstract available


  241. STEINBECK G, Sinner MF, Lutz M, Muller-Nurasyid M, et al
    Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014.
    Eur Heart J. 2018 Aug 1. pii: 5063863. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  242. PATHAK RK, Sanders P, Deo R
    Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy.
    Eur Heart J. 2018 Jul 17. pii: 5055243. doi: 10.1093.
    PubMed     Abstract available


  243. COWAN JC, Wu J, Hall M, Orlowski A, et al
    A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
    Eur Heart J. 2018 Jul 5. pii: 5049393. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  244. MAROTT JL, Skielboe AK, Dixen U, Friberg JB, et al
    Increasing population height and risk of incident atrial fibrillation: the Copenhagen City Heart Study.
    Eur Heart J. 2018 Jun 28. pii: 5046683. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  245. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2018;39:1851-1860.
    PubMed     Abstract available


  246. FRIEDMAN DJ, Granger CB
    Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
    Eur Heart J. 2018 May 19. pii: 4999868. doi: 10.1093.
    PubMed    


    April 2018
  247. FANAROFF AC, Steffel J, Alexander JH, Lip GYH, et al
    Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe.
    Eur Heart J. 2018 Apr 23. pii: 4982606. doi: 10.1093.
    PubMed     Abstract available


  248. LUSCHER TF
    Atrial fibrillation and arrhythmias: novel risk assessment, proper anticoagulation, and ablation.
    Eur Heart J. 2018;39:1317-1321.
    PubMed    


  249. CONEN D
    Epidemiology of atrial fibrillation.
    Eur Heart J. 2018;39:1323-1324.
    PubMed    


  250. GOLWALA HB, Cannon CP, Steg PG, Doros G, et al
    Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2018 Apr 13. pii: 4970508. doi: 10.1093.
    PubMed     Abstract available


  251. EZEKOWITZ MD, Pollack CV Jr, Halperin JL, England RD, et al
    Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
    Eur Heart J. 2018 Apr 6. pii: 4963487. doi: 10.1093.
    PubMed     Abstract available


  252. BELLMANN B, Plenge T, Sultan A, Steven D, et al
    First endocardial mapping of the left ventricle using the AdvisorTM HD Grid Catheter in a patient with a mitral valve clip.
    Eur Heart J. 2018 Apr 2. pii: 4958789. doi: 10.1093.
    PubMed    


    March 2018
  253. POKORNEY SD, Daubert JP
    Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug?
    Eur Heart J. 2018 Mar 27. pii: 4955289. doi: 10.1093.
    PubMed    


  254. KIRCHHOF P, Haeusler KG, Blank B, De Bono J, et al
    Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.
    Eur Heart J. 2018 Mar 20. pii: 4943979. doi: 10.1093.
    PubMed     Abstract available


  255. STEFFEL J, Verhamme P, Potpara TS, Albaladejo P, et al
    The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Eur Heart J. 2018 Mar 17. pii: 4942493. doi: 10.1093.
    PubMed     Abstract available


  256. WALDMANN V, Bougouin W, Karam N, Dumas F, et al
    Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
    Eur Heart J. 2018 Mar 16. pii: 4939309. doi: 10.1093.
    PubMed     Abstract available


  257. HASEGAWA K, Kaseno K, Aiki T, Tada H, et al
    Left atrial sarcoidosis as a substrate for peri-mitral atrial flutter: an unusual, underlying atrial disease.
    Eur Heart J. 2018 Mar 15. pii: 4938722. doi: 10.1093.
    PubMed    


    February 2018
  258. LANCELLOTTI P, Galderisi M
    Prediction of ischaemic stroke in non-valvular atrial fibrillation if advanced echocardiography plays the game.
    Eur Heart J. 2018 Feb 9. pii: 4847811. doi: 10.1093.
    PubMed    


  259. RIENSTRA M, Hobbelt AH, Alings M, Tijssen JGP, et al
    Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.
    Eur Heart J. 2018 Feb 1. pii: 4786620. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  260. MAHAJAN R, Perera T, Elliott AD, Twomey DJ, et al
    Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis.
    Eur Heart J. 2018 Jan 10. pii: 4797540. doi: 10.1093.
    PubMed     Abstract available


  261. HEALEY JS
    The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation.
    Eur Heart J. 2018 Jan 9. pii: 4796907. doi: 10.1093.
    PubMed    


  262. LIP GYH, Lane DA, Potpara TS
    Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.
    Eur Heart J. 2018 Jan 6. pii: 4791955. doi: 10.1093.
    PubMed    


  263. HEINZMANN D, Seizer P
    Mitochondria in heart failure: EMID-sign.
    Eur Heart J. 2018 Jan 3. pii: 4786075. doi: 10.1093.
    PubMed    


  264. DESTEGHE L, Vijgen J, Koopman P, Dilling-Boer D, et al
    Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.
    Eur Heart J. 2018 Jan 2. pii: 4782504. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  265. LEUNG M, van Rosendael PJ, Abou R, Ajmone Marsan N, et al
    Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry.
    Eur Heart J. 2017 Dec 28. pii: 4781364. doi: 10.1093.
    PubMed     Abstract available


  266. VERHEUGT FWA, Gao H, Al Mahmeed W, Ambrosio G, et al
    Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
    Eur Heart J. 2017 Dec 20. pii: 4769347. doi: 10.1093.
    PubMed     Abstract available


  267. POKORNEY SD, Granger CB
    Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation.
    Eur Heart J. 2017 Dec 13. pii: 4735276. doi: 10.1093.
    PubMed    


  268. DUYTSCHAEVER M, Demolder A, Phlips T, Sarkozy A, et al
    PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial.
    Eur Heart J. 2017 Dec 2. pii: 4683714. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  269. SPOSATO LA, Lopes RD
    Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation?
    Eur Heart J. 2017 Nov 27. pii: 4665696. doi: 10.1093.
    PubMed    


  270. PICCINI JP, Kirchhof P
    Improving outcomes after catheter ablation of atrial fibrillation: better patient selection, better procedure, or both?
    Eur Heart J. 2017 Nov 22. pii: 4652880. doi: 10.1093.
    PubMed    


  271. STAERK L, Fosbol EL, Lamberts M, Bonde AN, et al
    Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2017 Nov 18. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  272. FRIBERG L, Rosenqvist M
    Less dementia with oral anticoagulation in atrial fibrillation.
    Eur Heart J. 2017 Oct 24. doi: 10.1093.
    PubMed     Abstract available


  273. LIP GYH, Lane DA, Sarwar S
    Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation.
    Eur Heart J. 2017;38:2980-2982.
    PubMed    


  274. HIJAZI Z, Oldgren J, Lindback J, Alexander JH, et al
    A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Abstract available


  275. DELISLE BP, January CT
    Advancing precision medicine for the treatment of long-QT syndrome type 2: shedding light on lumacaftor.
    Eur Heart J. 2017 Oct 11. doi: 10.1093.
    PubMed    


    September 2017
  276. KOTECHA D, Kirchhof P
    ESC Apps for Atrial Fibrillation.
    Eur Heart J. 2017;38:2643-2645.
    PubMed    


  277. LUSCHER TF
    Risk factors and consequences of atrial fibrillation: genetics, blood pressure, working hours, and cognitive decline.
    Eur Heart J. 2017;38:2573-2575.
    PubMed    


  278. KIRCHHOF P, Sanders P
    My atrial fibrillation is not your atrial fibrillation.
    Eur Heart J. 2017;38:2608-2611.
    PubMed    


  279. MAHMOODI BK, Boersma LV
    Do long working hours predispose to atrial fibrillation?
    Eur Heart J. 2017;38:2629-2631.
    PubMed    


  280. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Abstract available


    August 2017
  281. PALLISGAARD JL, Gislason GH, Hansen J, Johannessen A, et al
    Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed     Abstract available


  282. KIRCHHOF P, Schroeder S
    NOACs in Atrial Fibrillation.
    Eur Heart J. 2017;38:2382-2385.
    PubMed    


  283. GRIGIONI F, Clavel MA, Vanoverschelde JL, Tribouilloy C, et al
    The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    PubMed     Abstract available


    July 2017
  284. MEHTA A, Ramachandra CJA, Singh P, Chitre A, et al
    Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model.
    Eur Heart J. 2017 Jul 21. doi: 10.1093.
    PubMed     Abstract available


    June 2017
  285. LEE SS, Ae Kong K, Kim D, Lim YM, et al
    Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea.
    Eur Heart J. 2017 Jun 28. doi: 10.1093.
    PubMed     Abstract available


  286. HUANG H, Darbar D
    Genetic heterogeneity of atrial fibrillation susceptibility loci across racial or ethnic groups.
    Eur Heart J. 2017 Jun 14. doi: 10.1093.
    PubMed    


  287. DIENER HC
    Does atrial fibrillation lead to cognitive decline and dementia?
    Eur Heart J. 2017 Jun 14. doi: 10.1093.
    PubMed    


    May 2017
  288. LUSCHER TF
    Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy.
    Eur Heart J. 2017;38:1443-1446.
    PubMed    


    April 2017
  289. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Abstract available


  290. LEE JY, Kim TH, Yang PS, Lim HE, et al
    Korean atrial fibrillation network genome-wide association study for early-onset atrial fibrillation identifies novel susceptibility loci.
    Eur Heart J. 2017 Apr 27. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  291. RAHIMI K
    Subclinical atrial fibrillation in need of more assertive evidence.
    Eur Heart J. 2017 Mar 31. doi: 10.1093.
    PubMed    


  292. SETO AH, Abbott NJ, Makkar RR, Salazar MA, et al
    Sustained left ventricular outflow tract ventricular tachycardia following transcatheter aortic valve replacement.
    Eur Heart J. 2017 Mar 28. doi: 10.1093.
    PubMed    



  293. Corrigendum to: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS'.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed    


  294. CAMM AJ, Savelieva I
    Female gender as a risk factor for stroke associated with atrial fibrillation.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed    


  295. LUSCHER TF
    Atrial fibrillation and thrombo- embolism: anticoagulants or devices?
    Eur Heart J. 2017;38:839-842.
    PubMed    


  296. ABDUL-RAHIM AH, Perez AC, MacIsaac RL, Jhund PS, et al
    Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
    Eur Heart J. 2017;38:742-750.
    PubMed     Abstract available


  297. BAX JJ, Delgado V, Sogaard P, Singh JP, et al
    Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial.
    Eur Heart J. 2017;38:720-726.
    PubMed     Abstract available


  298. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    PubMed     Abstract available


    February 2017
  299. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
    Eur Heart J. 2017 Feb 21. doi: 10.1093.
    PubMed     Abstract available


  300. AKDIS D, Saguner AM, Shah K, Wei C, et al
    Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.
    Eur Heart J. 2017 Feb 18. doi: 10.1093.
    PubMed     Abstract available


    January 2017
  301. REINER MF, Breitenstein A, Holy EW, Glanzmann M, et al
    Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
    Eur Heart J. 2017 Jan 8. pii: ehw578. doi: 10.1093.
    PubMed     Abstract available


  302. BAVENDIEK U, Aguirre Davila L, Koch A, Bauersachs J, et al
    Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.
    Eur Heart J. 2017 Jan 8. pii: ehw577. doi: 10.1093.
    PubMed    


  303. GAL P, Marrouche NF
    Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome.
    Eur Heart J. 2017;38:14-19.
    PubMed     Abstract available


    September 2016
  304. PICCINI JP, Sievert H, Patel MR
    Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Eur Heart J. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: